174 related articles for article (PubMed ID: 24667647)
1. Biological significance of fluorine-18-α-methyltyrosine (FAMT) uptake on PET in patients with oesophageal cancer.
Suzuki S; Kaira K; Ohshima Y; Ishioka NS; Sohda M; Yokobori T; Miyazaki T; Oriuchi N; Tominaga H; Kanai Y; Tsukamoto N; Asao T; Tsushima Y; Higuchi T; Oyama T; Kuwano H
Br J Cancer; 2014 Apr; 110(8):1985-91. PubMed ID: 24667647
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic usefulness of ¹⁸F-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma.
Nobusawa A; Kim M; Kaira K; Miyashita G; Negishi A; Oriuchi N; Higuchi T; Tsushima Y; Kanai Y; Yokoo S; Oyama T
Eur J Nucl Med Mol Imaging; 2013 Oct; 40(11):1692-700. PubMed ID: 23801167
[TBL] [Abstract][Full Text] [Related]
3. Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET.
Wiriyasermkul P; Nagamori S; Tominaga H; Oriuchi N; Kaira K; Nakao H; Kitashoji T; Ohgaki R; Tanaka H; Endou H; Endo K; Sakurai H; Kanai Y
J Nucl Med; 2012 Aug; 53(8):1253-61. PubMed ID: 22743251
[TBL] [Abstract][Full Text] [Related]
4. L-[3-18F]-α-methyltyrosine accumulation as a definitive chemoradiotherapy response predictor in patients with esophageal cancer.
Sohda M; Honjyo H; Hara K; Ozawa D; Suzuki S; Tanaka N; Sano A; Sakai M; Yokobori T; Inose T; Miyazaki T; Ojima H; Higuchi T; Tsushima Y; Kuwano H
Anticancer Res; 2014 Feb; 34(2):909-13. PubMed ID: 24511031
[TBL] [Abstract][Full Text] [Related]
5. Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study.
Kaira K; Oriuchi N; Otani Y; Shimizu K; Tanaka S; Imai H; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Dobashi K; Kanai Y; Endou H; Nakajima T; Endo K; Mori M
Clin Cancer Res; 2007 Nov; 13(21):6369-78. PubMed ID: 17975149
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of ¹⁸F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with ¹⁸F-FDG PET/CT and MRI.
Kim M; Higuchi T; Arisaka Y; Achmad A; Tokue A; Tominaga H; Miyashita G; Miyazaki H; Negishi A; Yokoo S; Tsushima Y
Ann Nucl Med; 2013 Jun; 27(5):423-30. PubMed ID: 23436243
[TBL] [Abstract][Full Text] [Related]
7. Uptake of positron emission tomography tracers reflects the tumor immune status in esophageal squamous cell carcinoma.
Kuriyama K; Higuchi T; Yokobori T; Saito H; Yoshida T; Hara K; Suzuki S; Sakai M; Sohda M; Higuchi T; Tsushima Y; Asao T; Kaira K; Kuwano H; Shirabe K; Saeki H
Cancer Sci; 2020 Jun; 111(6):1969-1978. PubMed ID: 32302443
[TBL] [Abstract][Full Text] [Related]
8. L-[3-¹⁸F]-α-methyltyrosine uptake by lymph node metastasis is a predictor of complete response to CRT in esophageal cancer.
Sohda M; Miyazaki T; Honjyo H; Hara K; Ozawa D; Suzuki S; Tanaka N; Sano A; Sakai M; Yokobori T; Nakajima M; Fukuchi M; Kato H; Higuchi T; Tsushima Y; Kuwano H
Anticancer Res; 2014 Dec; 34(12):7473-7. PubMed ID: 25503190
[TBL] [Abstract][Full Text] [Related]
9. ¹⁸F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: comparative study with ¹⁸F-FDG PET and immunohistochemistry.
Miyashita G; Higuchi T; Oriuchi N; Arisaka Y; Hanaoka H; Tominaga H; Morita S; Miyakubo M; Ishikita T; Nakasone Y; Negishi A; Yokoo S; Endo K
Ann Nucl Med; 2010 Oct; 24(8):579-84. PubMed ID: 20652456
[TBL] [Abstract][Full Text] [Related]
10. Transport of 3-fluoro-L-α-methyl-tyrosine (FAMT) by organic ion transporters explains renal background in [(18)F]FAMT positron emission tomography.
Wei L; Tominaga H; Ohgaki R; Wiriyasermkul P; Hagiwara K; Okuda S; Kaira K; Kato Y; Oriuchi N; Nagamori S; Kanai Y
J Pharmacol Sci; 2016 Feb; 130(2):101-9. PubMed ID: 26887331
[TBL] [Abstract][Full Text] [Related]
11. Relationship Between Tumor Immune Markers and Fluorine-18-α-Methyltyrosine ([
Shimizu K; Kaira K; Higuchi T; Hisada T; Yokobori T; Oyama T; Asao T; Tsushima Y; Shirabe K
Mol Imaging Biol; 2020 Aug; 22(4):1078-1086. PubMed ID: 31792836
[TBL] [Abstract][Full Text] [Related]
12. Biological evaluation of 3-[(18)F]fluoro-α-methyl-D-tyrosine (D-[(18)F]FAMT) as a novel amino acid tracer for positron emission tomography.
Ohshima Y; Hanaoka H; Tominaga H; Kanai Y; Kaira K; Yamaguchi A; Nagamori S; Oriuchi N; Tsushima Y; Endo K; Ishioka NS
Ann Nucl Med; 2013 May; 27(4):314-24. PubMed ID: 23337966
[TBL] [Abstract][Full Text] [Related]
13. 18F-FAMT-PET is useful for the diagnosis of lymph node metastasis in operable esophageal squamous cell carcinoma.
Sohda M; Kato H; Suzuki S; Tanaka N; Sano A; Sakai M; Inose T; Nakajima M; Miyazaki T; Fukuchi M; Oriuchi N; Endo K; Kuwano H
Ann Surg Oncol; 2010 Dec; 17(12):3181-6. PubMed ID: 20614194
[TBL] [Abstract][Full Text] [Related]
14. Distribution of LAT1-targeting PET tracer was independent of the tumor blood flow in rat xenograft models of C6 glioma and MIA PaCa-2.
Aoki M; Watabe T; Nagamori S; Naka S; Ikeda H; Kongpracha P; Horitsugi G; Kanai Y; Shimosegawa E; Kanai Y; Hatazawa J
Ann Nucl Med; 2019 Jun; 33(6):394-403. PubMed ID: 30820863
[TBL] [Abstract][Full Text] [Related]
15. Use of pre-treatment 18F-FAMT PET to predict patient survival in squamous cell carcinoma of the esophagus treated by curative surgery.
Sohda M; Sakai M; Honjyo H; Hara K; Ozawa D; Suzuki S; Tanaka N; Yokobori T; Miyazaki T; Fukuchi M; Higuchi T; Tsushima Y; Kuwano H
Anticancer Res; 2014 Jul; 34(7):3623-8. PubMed ID: 24982378
[TBL] [Abstract][Full Text] [Related]
16. Specific transport of 3-fluoro-l-α-methyl-tyrosine by LAT1 explains its specificity to malignant tumors in imaging.
Wei L; Tominaga H; Ohgaki R; Wiriyasermkul P; Hagiwara K; Okuda S; Kaira K; Oriuchi N; Nagamori S; Kanai Y
Cancer Sci; 2016 Mar; 107(3):347-52. PubMed ID: 26749017
[TBL] [Abstract][Full Text] [Related]
17. 18F-FAMT PET Is Useful to Distinguish between Specific Uptake and Nonspecific Uptake Compared to 18F-Flourodeoxyglucose Position Emission Tomography in Esophageal Cancer Patients.
Sohda M; Miyazaki T; Honjyo H; Hara K; Ozawa D; Sakai M; Yokobori T; Higuchi T; Tsushima Y; Kuwano H
Dig Surg; 2018; 35(5):383-388. PubMed ID: 29130979
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of thoracic tumors with (18)F-FMT and (18)F-FDG PET-CT: a clinicopathological study.
Kaira K; Oriuchi N; Shimizu K; Ishikita T; Higuchi T; Imai H; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Endou H; Nakajima T; Endo K; Mori M
Int J Cancer; 2009 Mar; 124(5):1152-60. PubMed ID: 19065657
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of 18F-α-Methyltyrosine PET for Therapeutic Monitoring of Patients with Advanced Lung Cancer.
Kaira K; Higuchi T; Sunaga N; Arisaka Y; Hisada T; Tominaga H; Oriuchi N; Asao T; Tsushima Y; Yamada M
Anticancer Res; 2016 Dec; 36(12):6481-6490. PubMed ID: 27919971
[TBL] [Abstract][Full Text] [Related]
20. Effects of intratumoral inflammatory process on 18F-FDG uptake: pathologic and comparative study with 18F-fluoro-α-methyltyrosine PET/CT in oral squamous cell carcinoma.
Kim M; Achmad A; Higuchi T; Arisaka Y; Yokoo H; Yokoo S; Tsushima Y
J Nucl Med; 2015 Jan; 56(1):16-21. PubMed ID: 25476535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
